Caris Life Sciences (CAI) Times Interest Earned (2024 - 2026)
Caris Life Sciences' (CAI) quarterly Times Interest Earned came in at $0.41 in Q1 2026, up 109.1% year-on-year from $0.2 in Q1 2025, and up 100.92% quarter-over-quarter from -$44.72 in Q4 2025.
Caris Life Sciences (CAI) Times Interest Earned (2024 - 2026) Analysis & Trends
Caris Life Sciences' Times Interest Earned history runs 3 years deep, the most recent figure standing at $0.41 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 109.1% year-over-year to $0.41 in Q1 2026; TTM through Mar 2026 was -$58.5, a 288.24% decrease from a year earlier, with the FY2025 full-year figure at $0.11, up 118.02% from the prior year.
- Times Interest Earned improved to $0.41 in Q1 2026 per CAI's latest filing, from -$44.72 in the prior quarter.
- Across five years, Times Interest Earned topped out at $1.45 in Q4 2024 and bottomed at -$44.72 in Q4 2025.
- The 3-year median for Times Interest Earned is -$2.23 (2024), against an average of -$7.08.
- Across the five-year window, Times Interest Earned tumbled 3174.11% in 2025 and surged 109.1% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at $1.45 in 2024, then tumbled by 3174.11% to -$44.72 in 2025, then soared by 100.92% to $0.41 in 2026.
- Per Business Quant, the three latest CAI Times Interest Earned figures stand at $0.41 (Q1 2026), -$44.72 (Q4 2025), and $0.07 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Caris Life Sciences | 4.42 Bn | 3.60 Bn | 214.23 Mn | 0.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.41 |
| Dec 31, 2025 | -44.72 |
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | -0.05 |
| Mar 31, 2025 | -4.53 |
| Dec 31, 2024 | 1.45 |
| Sep 30, 2024 | -4.41 |
| Jun 30, 2024 | -4.90 |